Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06356285
Other study ID # 6995049
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 10, 2024
Est. completion date June 1, 2024

Study information

Verified date April 2024
Source Imperial College London
Contact Kate Grailey
Phone 07912563290
Email k.grailey18@imperial.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to investigate the public's views on antibiotics and the impact of different ways to name the potential consequences of antibiotics not working in the future. It is known that current ways to name this don't resonate well with the public, and the study team have worked with members of the public through focus groups and community workshops to develop new ways of describing this in a process of co-design. This study aims to test four different ways of presenting this potential crisis to the public, some of which are new communication strategies designed by the public themselves, to evaluate which are the most memorable and investigate the impact on behaviour change. Adults aged over 18, living in the United Kingdom, who have already signed up to a market panel research company will be eligible to participate in this study. Participants will be invited to complete a short online survey (this should take around five minutes), advertised to them by the market research panel they have already signed up to. This survey is completely anonymous, and contains some multiple-choice questions, and some that require a short free text response. At the start of the survey one of the four ways to name AMR will be presented to participants in the form of a poster. This study aims to result in an improved understanding regarding the general public's understanding of antibiotic use and investigate the impact of communication on behaviour change. The data from this study may be used to inform future public health campaigns on this topic and improve the use of antibiotics. This study will be conducted online using the Predictiv platform, an online platform built by the Behavioural Insights Team. The study is being run in collaboration between the Behavioural Insights Team and the Institute of Global Health Innovation at Imperial College London. Is it anticipated that the survey will open in April 2024 and be open until recruitment of 4000 participants is complete. This is expected to take 4-6 weeks.


Description:

Antimicrobial resistance (AMR) refers to the process by which bacteria become resistant to antibiotics, rendering them ineffective in treating infections. Public behaviour change is needed to use antibiotics more sparingly and wisely (for example, only taking them when needed and finishing the course). However, studies and public engagement work have shown that the current language around the crisis of AMR is not well known or understood by the general public. It is felt to be too scientific, not memorable, and doesn't convey sufficient meaning to inspire behaviour change. Building on previous studies, this project aims to identify whether different ways to present or frame Antimicrobial Resistance (AMR) can lead to improved comprehension and change attitudes towards the crisis. Through extensive public engagement and involvement work three different ways to frame AMR to the public have been developed. One of these ways is a novel name developed through co-design with public members, and the other two were existing terms that the public believed were better than AMR during our engagement activities. An online randomised controlled trial (RCT) has been designed to test these three names against the control of AMR/Antimicrobial resistance, to see if they can improve comprehension, attitudes towards and recall of the subject. This online RCT will be delivered in collaboration with the Behavioural Insights Team using their well established online platform, called Predictiv. 4,000 participants will be recruited (to be representative of the UK population). They will see one of our four names (this will be presented in the typical community setting of seeing a poster at a bus stop), and be asked to complete a short five minute survey, answering a series of questions to explore their understanding of the topic and their future attitudes to antibiotic use. Statistical analysis will be conducted to see which of the four communication strategies were most effective across the different outcomes, helping us to understand which communication strategies for AMR are most useful at inspiring behaviour change. Data will additionally be analysed to explore whether different messaging strategies are more effective in certain population subgroups - for example by age or previous antibiotic use.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 4000
Est. completion date June 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults aged over 18 - Resident in the United Kingdom (UK) - Have passed the attention check at the start of the online survey. Exclusion Criteria: - Individuals not signed up a market research panel, and will therefore not have access to the online survey - Those resident outside the UK - Those who fail the attention check at the start of the online survey. - Individuals aged under 18.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Presentation of Antimicrobial Resistance
Participants will be presented with a poster containing information about antibiotics, each intervention poster will have a different name at the top, representing a new way to frame antimicrobial resistance.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Imperial College London The Behavioural Insights Team

Outcome

Type Measure Description Time frame Safety issue
Other Impact on population sub-groups Explore the differing impact of different ways to present AMR on population sub-characteristics, including age, ethnicity and previous antibiotic use.
This will be conducted using a subgroup analysis of the overall sentiment model, using a quasi-binomial regression model.
Subgroups include:
Existing familiarity (Yes; No)
Taken antibiotics in past year (Yes; No)
Age (18-34; 25-39; 40-54; 55+)
Ethnicity (White; Non-White)
6 weeks
Primary Attitudes towards Antimicrobial Resistance (Sentiment) Evaluation of participant's attitudes towards antimicrobial resistance, related to questions within the survey that assess sentiment (including agreement that antimicrobial resistance is an urgent issue that needs to be addressed, antimicrobial resistance poses a risk to human health and antimicrobial resistance is an issue that may impact the participants own health).
This will be conducted using a quasi-binominal regression model using the sum of binary ratings of sub-sentiment questions as the primary outcome analysis.
6 weeks
Secondary Comprehension Comprehension of the meaning of Antimicrobial Resistance, related to questions within the survey that evaluate comprehension (what has caused antimicrobial resistance, what is the solution to antimicrobial resistance, what antimicrobial resistance is).
This will be conducted using a quasi-binominal regression model using the number of correct answers to comprehension questions.
6 weeks
Secondary Intent Intention regarding antibiotic use in the context of antimicrobial resistance related to questions within the survey that evaluate intent - asking participants about whether they would request antibiotics in certain scenarios.
This will be conducted using a separate logistic regression for each scenario (binary - Yes or No).
6 weeks
Secondary Recall Recall of the term used to describe antimicrobial resistance in the intervention. This will be conducted using a separate logistic regression for each question (asking about recall of the name at the top of the poster and the content of the poster) (binary - Yes or No). 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT04182230 - UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections
Recruiting NCT02814877 - Efficacy and Cost-effectiveness of Hospital Antimicrobial Stewardship Programs N/A
Completed NCT03388944 - PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis N/A
Completed NCT05734391 - Surveillance of Healthcare-associated Infections & Antimicrobial Resistance
Completed NCT03794479 - Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Recruiting NCT05942157 - Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections N/A
Recruiting NCT05296837 - Ocular Rosacea Biome Study Phase 4
Completed NCT05451836 - N-of-1 Trials of Interventions to Improve Decision-making for Antibiotic Use N/A
Not yet recruiting NCT05960084 - Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia
Completed NCT05445414 - A Mobile App Serious Game to Increase Awareness of Antibiotic Use in the Community N/A
Not yet recruiting NCT05089760 - Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China
Recruiting NCT04388293 - Using Antibiotics Wisely - An Antimicrobial Stewardship Program
Recruiting NCT05285657 - Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases. N/A
Completed NCT03479710 - Fecal Microbiota Transplantation for CRE/VRE Phase 2
Not yet recruiting NCT06358872 - Azithromycin for Child Survival in Niger II Phase 4
Not yet recruiting NCT06305455 - Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship